SIA
GILD icon

Starfire Investment Advisers’s Gilead Sciences GILD Stock Holding History

Starfire Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,620
Closed -$259K – 177
2017
Q4 		$259K Buy
+3,620
New +$275K 0.21% 133

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Starfire Investment Advisers's GILD Position: Q1 2018 in Review

Starfire Investment Advisers sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 3,620 shares — an estimated $259K sold.

Starfire Investment Advisers first reported a position in GILD in Q4 2017 and held it in 1 quarter. The position peaked at $259K in Q4 2017. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Starfire Investment Advisers reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Starfire Investment Advisers sold 3,620 Gilead Sciences shares in Q1 2018, an estimated $259K.
  • Starfire Investment Advisers first reported a position in Gilead Sciences in Q4 2017 and held it in 1 quarter.
  • Starfire Investment Advisers's Gilead Sciences position peaked at $259K in Q4 2017.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Starfire Investment Advisers's 13F filing for Q1 2018, filed 20 Apr 2018.